Account
WATConsult bags digital creative mandate for TripMoney
Mumbai: WATConsult, an Isobar company & hybrid digital agency from dentsu India has bagged the digital creative mandate for TripMoney, the fintech enterprise from the MakeMyTrip group. The account was won following a competitive pitch process and will be managed by the agency’s Delhi office.
As per the mandate, WATConsult will be responsible for digital creatives, social media management and content marketing. It will also include strategising and amplifying TripMoney’s social media presence across platforms to increase engagement and brand recall, said the statement.
The agency will be working in tandem with the marketing team at TripMoney to craft strategies and initiate campaigns that are aligned with the brand’s goals, it added.
“Our aim is to engage with customers through meaningful marketing and communication interventions across platforms by highlighting the various utilitarian benefits of using TripMoney and its offerings,” said Go-Ibibo and TripMoney brand head Abhinav Narula. “We are looking forward to this new journey together with WATConsult.”
On winning the mandate, Isobar India group CEO Heeru Dingra added, “We are thrilled to have this opportunity to partner with TripMoney. I believe it is WATConsult’s in-depth understanding of social media, our consumer-centric approach and data-driven insights that got us on board. We look forward to a great association ahead.”
“With the travel restrictions being lifted and many venturing out like before, TripMoney easing travel from a financial POV, becomes a lot more relevant now,” stated WATConsult managing partner Sahil Shah. “We are excited to partner up with this new-age brand that will give us a blank canvas to paint on. We look forward to doing some great creative digital campaigns going forward.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”







